|
HS Code |
405160 |
| Chemical Name | L-1,2,3,4-Tetrahydronorharman-3-Carboxylic Acid |
| Molecular Formula | C11H13NO2 |
| Molecular Weight | 191.23 g/mol |
| Cas Number | 94279-99-9 |
| Appearance | White to off-white solid |
| Solubility | Soluble in water and organic solvents |
| Melting Point | 192-195°C |
| Purity | Typically >98% |
| Storage Temperature | 2-8°C |
| Synonyms | L-Tetrahydronorharman-3-carboxylic acid |
| Smiles | C1CNCC2=C1C=CC(=C2)C(=O)O |
| Iupac Name | (1S)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid |
As an accredited L-1,2,3,4-Tetrahydronorharman-3-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 250g of L-1,2,3,4-Tetrahydronorharman-3-Carboxylic Acid is sealed in a labeled amber glass bottle with tamper-evident cap. |
| Shipping | **Shipping Description:** L-1,2,3,4-Tetrahydronorharman-3-Carboxylic Acid should be shipped in tightly sealed containers, protected from moisture and light. Transport under ambient temperature conditions unless otherwise specified. Comply with local and international regulations for chemical substances. Ensure robust packaging to prevent leaks or spills during handling and transit. |
| Storage | L-1,2,3,4-Tetrahydronorharman-3-Carboxylic Acid should be stored in a tightly sealed container, protected from light and moisture. Keep it at 2-8°C (refrigerated) and in a well-ventilated, dry area away from incompatible substances such as strong oxidizing agents. Ensure proper labeling and avoid prolonged exposure to air to maintain chemical stability and purity. |
Applications of L-1,2,3,4-Tetrahydronorharman-3-Carboxylic Acid in Industrial ManufacturingAs a dedicated manufacturer, we supply L-1,2,3,4-Tetrahydronorharman-3-Carboxylic Acid to global industrial downstream sectors where its unique structure delivers essential intermediate or additive functions within strictly regulated production environments. Below we outline established applications across specialized domains, highlighting application-specific compliance, formulation dosage, process incorporation, and resulting finished products. 1. Chiral Intermediate for Antihypertensive Drug SynthesisPharmaceutical manufacturers incorporate this compound as a chiral precursor to synthesize β-carboline-derived antihypertensive agents. Its defined stereochemistry supports the assembly of enantiopure active pharmaceutical ingredients (APIs) through selective condensation and cyclization reactions. Stringent controls over impurity profiles and batch reproducibility align with regulated GMP processes in commercial bulk drug production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Precursor for Alkaloid-Based Agrochemical SynthesisAgrochemical companies employ the material as a starting building block in the industrial synthesis of tetrahydro-β-carboline-based natural insecticides and fungicides. Its presence in the initial synthetic stage supports functionalization routes leading to bioactive amine derivatives authorized for crop protection. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Enzymatic Substrate for Food Biocatalysis R&DSpecialized food ingredient producers utilize this compound as a test substrate in biocatalyst screening programs to generate flavor precursors and minor indole alkaloids through controlled fermentation. Adherence to food-grade production protocols and residue monitoring is necessary before integration into further food ingredient development. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Intermediate for Specialty Dyes and PigmentsIndustrial colorant producers exploit the fused ring architecture of this material in the synthesis of specialty dyes for analytical and biological applications. The compound acts as a backbone in the preparation of extended aromatic systems needed for high-performance pigment production, with full traceability and impurity control enforced during manufacture. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive L-1,2,3,4-Tetrahydronorharman-3-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years spent perfecting the synthesis of L-1,2,3,4-tetrahydronorharman-3-carboxylic acid have taught us that the real work in our field lies in the details that few outside a manufacturer’s lab ever see. Handling this heterocyclic compound day in and day out, we lean on our technical team’s trust in consistent methods and unwavering control of every critical variable. It's not just about achieving purity on a sheet of paper; it’s about delivering that purity in every gram, regardless of the batch size or year.
This compound’s backbone, built around the tetrahydro-β-carboline ring, presents a synthesis challenge even for experienced hands. Unlike some simpler analogs or less functionalized carbolines, there’s no shortcut to crystalline precision. Small deviations in enantiomeric purity or a vague method of purification show up downstream—during research, in advanced pharmaceutical intermediates, and sometimes even in commercial-scale fermentations where a minor impurity can throw off an entire bioprocess.
We prioritize tight controls on chiral integrity. Customers in peptide synthesis, pharmaceutical intermediates, and neuroscience research come to us not because there are no alternatives, but because they’ve seen the direct impact of consistent configuration and minimal batch-to-batch variation. In this chemistry, minor isomeric shifts or trace impurities sneak into data and biological readouts—so we keep analytical controls at the heart of production, rarely letting lots leave before matching our reference spectra in NMR, HPLC, and chiral assays.
Most end-users for L-1,2,3,4-tetrahydronorharman-3-carboxylic acid approach the molecule from a research or developmental perspective. The demand for precise materials rises with every new neurobiological model, peptide drug candidate, and custom agrochemical project leveraging the β-carboline core. Often, those who work at the bench or design new assays don’t get the full backstory on reproducibility.
Years of feedback from research labs, startup biotech ventures, and even big pharma R&D have demystified the real value of the compound’s consistent production. Some use it in developing enzyme inhibitors, making the most of the molecule’s similarity to naturally occurring biochemical intermediates. Others incorporate it in receptor studies to probe new neuroactive agents. A few groups have even expanded its range into crop protection and advanced materials.
Each application puts its own unique spin on the quality conversation. For instance, in peptide coupling, trace water content or microgram differences in chiral purity cause headaches for synthetic chemists, leading them to demand rigorous pre-shipment data. In receptor and transporter studies, even seemingly innocuous mineral traces from handling equipment can cloud results. Our plant layout, attention to inert conditions, and years of troubleshooting create tangible value for experts working at the molecular frontiers.
Controlling the manufacturing process for L-1,2,3,4-tetrahydronorharman-3-carboxylic acid means never cutting corners on basics: raw material traceability, consistent solvent use, and precise environmental monitoring. Each batch draws from starting materials that have been checked not just for purity, but also for consistent performance through trial syntheses.
We avoid short cycles in crystallization. There’s a temptation in this business to rush purification, especially when large orders from research clients back up. In practice, letting every batch settle with careful solvent choice picks up purity not seen in quick, high-throughput crystallizations. We run moisture checks, not once but several times, as final traces of solvent remain a major source of variability—one that doesn’t always show up in quick chromatographic runs but will haunt end-users in further transformations or solid-state work.
Final product quality draws from more than just one analytical number. We share complete HPLC traces and well-annotated NMR spectra, so customers get the full picture, including routine checks for by-products with similar retention times or unexpected shifts. Reproducibility isn’t a marketing term—it’s a result of running the same synthetic cycle, with careful time and temperature control, and knowing exactly how to adjust for subtle differences in equipment or batches of reagents.
One point that every chemist who has struggled through cyclization reactions or tricky reductions will appreciate: L-1,2,3,4-tetrahydronorharman-3-carboxylic acid does not tolerate sloppy technique. Minute contamination with catalyst residues, excess acid, or oxidized intermediates can introduce off-colors, spectral ghosts, or diminished activity that creeps into biological tests. We allocate permanent personnel to continually check glassware cleanliness, monitor filters for potential leachants, and strictly segregate equipment between synthetic phases.
Managing waste streams also brings unique challenges. The by-products from this synthesis, especially in larger scales, call for stringent environmental planning. We coordinate with on-site and off-site waste handlers, ensuring no trace material enters routine drains. Every production run factors in complete mass balance, and regular investment in solvent recycling supports both cost control and environmental stewardship.
Purification remains the make-or-break stage. Unlike some commodity molecules, simple column runs never achieve the right level of clarity. Recrystallizations demand patience—a trait honed over years of watching failures emerge from hurry or complacency. Shifts in solution pH, the presence of trace transition metals, or even humidity swings on humid summer days will alter the crystalline habit, leading to subtle impacts on solubility and handling. This on-the-ground experience means our team takes as much pride in avoiding problems as in solving them, and engages customers when unexpected results trigger deeper troubleshooting.
Comparisons with more widely used β-carbolines, such as harman or norharman derivatives, often come up in discussions with research partners. Researchers sometimes expect similar ease of handling, price points, or regulatory pathways. Yet those who have used our product recognize its specific benefits rooted in molecular structure and how that plays out in practice.
The tetrahydro-π-carboline ring grants greater flexibility for synthetic chemistry, contrasting sharply with fully aromatic variants that resist further modification or quickly form persistent impurities. In high-throughput screening, this flexibility supports more efficient derivatization, making it a preferable starting point for many custom syntheses. While aromatic β-carbolines hold a place in certain applications, the subtle hydrogenation here brings a different realm of reactivity without complicating downstream purification or triggering excess side reactions.
From a physical handling viewpoint, the differences stand out in day-to-day work. L-1,2,3,4-tetrahydronorharman-3-carboxylic acid resists caking, holds up during shipping, and stores with fewer stability issues compared to some less reduced or less substituted cousins. Stability over months in tightly sealed, opaque containers counters tendencies toward oxidation or degradation —a key pain point with many fragile heterocycles, and one that matters for slow-moving research stock.
Direct customer communication drives our process improvement cycles. Experienced chemists and formulation experts send us feedback not just on laboratory-scale outcomes but on how the material interacts with their equipment or processes at scale. Reports on easier dissolution, shortened filtration steps, and fewer unplanned cleanups echo back to our team—real incentives to double down on selected process routes and materials.
Over time, we have retooled several steps, investing in better reactor linings to reduce unexpected ionic contamination, and refining our drying protocols based on lessons learned from pilot batch anomalies. The result is a product trusted for decades in demanding applications—whether detailing the synaptic signaling pathways in animal models or building out a solid foundation in peptide drug conjugates.
This dialogue spills into technical support and troubleshooting. When a customer flags an outlier spectrum or points to a biological anomaly, our analytical group gets to work, sharing the full data and tracking the root cause. Years of partnership with core facilities and seasoned research leads have underscored the importance of immediate access to our technical files, not merely summary data. Our willingness to ship reference samples or even consult on downstream handling has built long-term relationships anchored in more than just order fulfillment.
Running commercial scale production teaches respect for slow, disciplined progress. Every advance in synthetic design or plant equipment adds complexity but opens the door to greater reliability and higher throughput. On the factory floor, investments in advanced filtration, gradual crystallization, and in-line quality tracking mean more than just numbers on a quarterly report; they translate directly into reduced downtime and sharper insight into day-to-day process behavior.
Our team leans on in-house analytical capacity and rigorous documentation, so we spot shifts in crystal habit or by-product signatures early. With a molecule like L-1,2,3,4-tetrahydronorharman-3-carboxylic acid, even half a percent drift sets off a review, often catching issues that would elude broader process windows. By refusing to treat technical deviations as trivial, we cement a foundation of trust with research and industrial users alike.
Supply interruptions, often driven by externalities such as raw material shortages or regulatory shifts, pressure-test the robustness of long-standing processes. Our experience navigating these waters, maintaining thorough raw material vetting, and developing secondary suppliers enables stable supply for complex projects running months or years. We build in inventory and logistics buffers based on hard-earned insight into the global chemical market, not just through theoretical models.
Access to L-1,2,3,4-tetrahydronorharman-3-carboxylic acid expands the toolkit available to academic research groups and startup innovators. We see a steady flow of grant-driven purchases from neurochemistry initiatives, crop science projects, and biosynthetic pathway modeling, each open to fresh possibilities due to the compound’s stability and consistent configuration.
Our support for these projects extends beyond standard order fulfillment. The technical discussions we have with principal investigators, lab managers, and postdoctoral researchers help refine our protocols and anticipate broader needs. Requests for specific crystal morphologies, alternate counterions, or modified drying cycles have prompted us to expand both capacity and quality controls. As these new directions take hold, we fold their lessons back into our regular production runs—in real time, not in abstract process development meetings.
Adjusting to the evolving research landscape means remaining alert to regulatory changes, safety expectations, and emerging testing standards. We maintain a rolling review of new toxicology findings, shipping and customs trends, and updated documentation, ensuring each lot aligns with the real-world setting it enters. This ongoing vigilance links seamlessly with our technical outreach, keeping the gap narrow between the developer’s vision and our manufacturer’s bench.
Our company’s technical expertise didn’t develop in a vacuum; it traces back through generations of chemists, operators, and analysts trained to respect the unpredictability of fine chemicals. Generational continuity helps sharpen skills and keep institutional memory alive, whether troubleshooting a recalcitrant batch or remediating minor environmental variances.
We rotate experienced technical staff through every step of production and quality control, encouraging hands-on familiarity with each stage, from raw material intake to finished product packaging. Lessons picked up in pilot batches help prevent large-scale problems. This approach continues to serve us in maintaining trust and adaptability, two qualities that matter just as much as analytical code compliance.
Occasionally, raw material quality dips or a filtration step behaves unpredictably. These aren’t signs of failure, but reminders of chemistry’s complexity. Addressing issues at their source not only prevents recurrence but often sheds light on overlooked aspects of process control. Feedback loops from the analytical lab to production to packaging remain a fixture of our everyday workflow.
As demand for specialized building blocks like L-1,2,3,4-tetrahydronorharman-3-carboxylic acid grows across industries, the pressure to meet new research and regulatory challenges only intensifies. Upcoming applications in biosensor development, targeted drug delivery, and sustainable catalysis have begun influencing both the scale and flexibility of our manufacturing lines.
Our response draws on past experience—balancing investment in new technologies with a commitment to the reliable, hands-on methods that have shaped us. Deployment of advanced in-line analytics and tighter process automation realize incremental improvements without sacrificing the adaptability or personal attention that define our daily operations.
There is rarely a single, fixed recipe for consistent success in fine chemical manufacturing. Ongoing research, customer experience, and critical peer dialogue inform every decision, from solvent choice to packing configuration. The ability to shift gears in response to unforeseen issues, regulatory reviews, or creative new uses signals both resilience and a core respect for the practical needs of modern science.
Supplying L-1,2,3,4-tetrahydronorharman-3-carboxylic acid provides a window into the broader landscape of chemical synthesis—where technical excellence, patient refinement, and a partnership mentality intersect and drive both innovation and reliability forward. Day after day, this experience reminds us that real quality resides not just in analytical numbers but in a hands-on, transparent approach built up over years at the bench and in the field.